$SGRY
Surgery Partners, Inc.

2024 Q2 Form 10-Q Financial Statement

#000163883324000113 Filed on May 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $762.1M $717.4M $666.2M
YoY Change 14.16% 7.69% 11.74%
Cost Of Revenue $560.7M $540.7M $510.8M
YoY Change 14.03% 5.85% 13.16%
Gross Profit $201.4M $176.7M $155.4M
YoY Change 14.5% 13.71% 7.32%
Gross Profit Margin 26.43% 24.63% 23.33%
Selling, General & Admin $62.50M $54.60M $53.40M
YoY Change 17.92% 2.25% 7.88%
% of Gross Profit 31.03% 30.9% 34.36%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $34.80M $33.70M $33.70M
YoY Change 42.62% 0.0% 22.99%
% of Gross Profit 17.28% 19.07% 21.69%
Operating Expenses $677.3M $641.4M $619.8M
YoY Change 788.85% 3.48% 25.01%
Operating Profit $84.80M $76.00M $46.40M
YoY Change -14.94% 63.79% -53.78%
Interest Expense -$51.50M -$47.30M -$46.80M
YoY Change 14.19% 1.07% -16.87%
% of Operating Profit -60.73% -62.24% -100.86%
Other Income/Expense, Net -$4.800M $400.0K $0.00
YoY Change -173.85%
Pretax Income $33.30M $28.70M -$400.0K
YoY Change -33.27% -7275.0% -100.91%
Income Tax $4.900M $4.400M -$1.600M
% Of Pretax Income 14.71% 15.33%
Net Earnings -$15.50M -$12.40M -$24.90M
YoY Change -182.01% -50.2% -304.1%
Net Earnings / Revenue -2.03% -1.73% -3.74%
Basic Earnings Per Share -$0.12 -$0.10 -$0.20
Diluted Earnings Per Share -$0.12 -$0.10 -$0.20
COMMON SHARES
Basic Shares Outstanding 127.1M shares 126.6M shares 126.0M shares
Diluted Shares Outstanding 126.1M shares 126.0M shares 125.2M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $213.5M $185.2M $245.5M
YoY Change 20.35% -24.56% -35.21%
Cash & Equivalents $213.5M $185.2M $245.5M
Short-Term Investments
Other Short-Term Assets $150.0M $107.7M $69.40M
YoY Change 33.21% 55.19% 37.15%
Inventory $80.90M $77.00M $71.80M
Prepaid Expenses $44.70M $31.70M $29.30M
Receivables $523.4M $494.3M $452.9M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.013B $895.9M $868.9M
YoY Change 24.97% 3.11% -7.27%
LONG-TERM ASSETS
Property, Plant & Equipment $1.273B $1.241B $1.118B
YoY Change 16.42% 10.93% 5.87%
Goodwill $4.806B $4.398B $4.217B
YoY Change 13.47% 4.27% 7.43%
Intangibles
YoY Change
Long-Term Investments $227.1M $188.7M $191.6M
YoY Change 18.16% -1.51% 102.75%
Other Assets $36.00M $112.4M $118.6M
YoY Change -84.6% -5.23% -1.17%
Total Long-Term Assets $6.476B $6.080B $5.774B
YoY Change 11.46% 5.29% 7.88%
TOTAL ASSETS
Total Short-Term Assets $1.013B $895.9M $868.9M
Total Long-Term Assets $6.476B $6.080B $5.774B
Total Assets $7.489B $6.976B $6.643B
YoY Change 13.11% 5.0% 5.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $174.0M $174.1M $144.4M
YoY Change 32.32% 20.57% 17.49%
Accrued Expenses $223.4M $222.3M $196.2M
YoY Change 16.17% 13.3% -14.51%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $92.40M $77.20M $62.90M
YoY Change 42.81% 22.73% -7.5%
Total Short-Term Liabilities $551.8M $523.4M $475.1M
YoY Change 20.32% 10.17% -12.39%
LONG-TERM LIABILITIES
Long-Term Debt $3.040B $2.794B $2.531B
YoY Change 21.35% 10.39% -16.34%
Other Long-Term Liabilities $21.10M $46.30M $80.20M
YoY Change -93.91% -42.27% -16.28%
Total Long-Term Liabilities $21.10M $46.30M $80.20M
YoY Change -99.26% -42.27% -16.28%
TOTAL LIABILITIES
Total Short-Term Liabilities $551.8M $523.4M $475.1M
Total Long-Term Liabilities $21.10M $46.30M $80.20M
Total Liabilities $572.9M $569.7M $555.3M
YoY Change -87.55% 2.59% -12.98%
SHAREHOLDERS EQUITY
Retained Earnings -$597.1M -$581.6M -$582.3M
YoY Change 6.0% -0.12% 18.72%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.952B $1.967B $1.962B
YoY Change
Total Liabilities & Shareholders Equity $7.489B $6.976B $6.643B
YoY Change 13.11% 5.0% 5.63%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$15.50M -$12.40M -$24.90M
YoY Change -182.01% -50.2% -304.1%
Depreciation, Depletion And Amortization $34.80M $33.70M $33.70M
YoY Change 42.62% 0.0% 22.99%
Cash From Operating Activities $82.80M $40.70M $74.50M
YoY Change 58.93% -45.37% -6.64%
INVESTING ACTIVITIES
Capital Expenditures $26.90M $21.00M $24.30M
YoY Change 4.26% -13.58% 33.52%
Acquisitions $54.60M $40.70M
YoY Change 34.15% 30.87%
Other Investing Activities -$217.2M $7.000M $4.100M
YoY Change 378.41% 70.73% -55.91%
Cash From Investing Activities -$244.1M -$83.10M -$70.70M
YoY Change 242.84% 17.54% 50.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $120.2M $15.90M
YoY Change 655.97% -6.47%
Cash From Financing Activities 189.6M $31.70M -$41.20M
YoY Change -486.94% -176.94% -5.72%
NET CHANGE
Cash From Operating Activities 82.80M $40.70M $74.50M
Cash From Investing Activities -244.1M -$83.10M -$70.70M
Cash From Financing Activities 189.6M $31.70M -$41.20M
Net Change In Cash 28.30M -$10.70M -$37.40M
YoY Change -141.56% -71.39% 240.0%
FREE CASH FLOW
Cash From Operating Activities $82.80M $40.70M $74.50M
Capital Expenditures $26.90M $21.00M $24.30M
Free Cash Flow $55.90M $19.70M $50.20M
YoY Change 112.55% -60.76% -18.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal Statement Of Income Extensible List
DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleList
http://www.surgerypartners.com/20240331#GainLossOnDispositionOfAssetsAndDeconsolidation
CY2024Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal Statement Of Income Extensible List
DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleList
http://www.surgerypartners.com/20240331#GainLossOnDispositionOfAssetsAndDeconsolidation
CY2024Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal Statement Of Income Extensible List
DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleList
http://www.surgerypartners.com/20240331#GainLossOnDispositionOfAssetsAndDeconsolidation
CY2023Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2024Q1 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2024Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2024Q1 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2023Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2024Q1 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations
CY2023Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations
CY2024Q1 us-gaap Oci Cash Flow Hedge Reclassification For Discontinuance Statement Of Income Or Comprehensive Income Extensible Enumeration
OciCashFlowHedgeReclassificationForDiscontinuanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#InterestIncomeExpenseNonoperatingNet
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
126593727 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
126593727 shares
CY2024Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
215200000 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
202200000 usd
CY2024Q1 us-gaap Supplies Expense
SuppliesExpense
188800000 usd
CY2023Q1 us-gaap Supplies Expense
SuppliesExpense
188400000 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
82600000 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
74600000 usd
CY2024Q1 sgry Operating And Finance Lease Expense
OperatingAndFinanceLeaseExpense
21400000 usd
CY2023Q1 sgry Operating And Finance Lease Expense
OperatingAndFinanceLeaseExpense
21400000 usd
CY2024Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
54100000 usd
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
45600000 usd
CY2024Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
562100000 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
532200000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
33200000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32000000.0 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33700000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33700000 usd
CY2024Q1 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
17400000 usd
CY2023Q1 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
12500000 usd
CY2024Q1 sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-1500000 usd
CY2023Q1 sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-10500000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2700000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3300000 usd
CY2024Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
1800000 usd
CY2023Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-3000000.0 usd
CY2024Q1 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
-2000000.0 usd
CY2023Q1 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
-800000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
641400000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
619800000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
76000000.0 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
46400000 usd
CY2024Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-47300000 usd
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-46800000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
28700000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-400000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4400000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1600000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
24300000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1200000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
36700000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
26100000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-12400000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-24900000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
125972000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
125206000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
125972000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
125206000 shares
CY2024Q1 us-gaap Profit Loss
ProfitLoss
24300000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1200000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
0 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-5500000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-11300000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
18800000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-10100000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
36700000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
26100000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17900000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-36200000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2940900000 usd
CY2023Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-6700000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3700000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-11300000 usd
CY2023Q1 sgry Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net
NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
46100000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
30200000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2942500000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3034500000 usd
CY2024Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
16900000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4900000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5500000 usd
CY2024Q1 sgry Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net
NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
16800000 usd
CY2024Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
29700000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3037900000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
24300000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1200000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33700000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33700000 usd
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
9000000.0 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
9000000.0 usd
CY2024Q1 sgry Noncash Interest Income Expense Net
NoncashInterestIncomeExpenseNet
-1500000 usd
CY2023Q1 sgry Noncash Interest Income Expense Net
NoncashInterestIncomeExpenseNet
-6500000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4900000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4200000 usd
CY2024Q1 sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-1500000 usd
CY2023Q1 sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-10500000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2500000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1800000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
-1000000.0 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
200000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5400000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8800000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
43100000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-2600000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
40700000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
74500000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21000000.0 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24300000 usd
CY2024Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
54600000 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
40700000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1500000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
8000000.0 usd
CY2024Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
2000000.0 usd
CY2023Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
9600000 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
7000000.0 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
4100000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-83100000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-70700000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
120200000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
15900000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
192500000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
15900000 usd
CY2024Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1300000 usd
CY2024Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
40500000 usd
CY2023Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
41900000 usd
CY2024Q1 us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
1400000 usd
CY2023Q1 us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
5100000 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1500000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-3100000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
31700000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-41200000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10700000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-37400000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
195900000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
282900000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
185200000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
245500000 usd
CY2024Q1 sgry Number Of Surgical Facilities Owned
NumberOfSurgicalFacilitiesOwned
165 facility
CY2024Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
33 state
CY2024Q1 sgry Number Of Surgical Facilities Owned Majority Interest
NumberOfSurgicalFacilitiesOwnedMajorityInterest
92 facility
CY2024Q1 sgry Number Of Surgical Facilities Owned Consolidated
NumberOfSurgicalFacilitiesOwnedConsolidated
124 facility
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Certain prior year amounts have been reclassified to conform with the current year presentation.
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.</span></div>
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
717400000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
666200000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.153
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
4.000
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
700000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-1800000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
4326000000 usd
CY2024Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
77500000 usd
CY2024Q1 us-gaap Goodwill Written Off Related To Sale Of Business Unit
GoodwillWrittenOffRelatedToSaleOfBusinessUnit
6000000.0 usd
CY2024Q1 us-gaap Goodwill
Goodwill
4397500000 usd
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
327400000 usd
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
342000000.0 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
7400000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
7800000 usd
CY2024Q1 sgry Redeemable Noncontrolling Interest Increase Decrease From Redemptions Or Purchase Of Interests
RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests
-300000 usd
CY2023Q1 sgry Redeemable Noncontrolling Interest Increase Decrease From Redemptions Or Purchase Of Interests
RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests
7700000 usd
CY2024Q1 sgry Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders
RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
10800000 usd
CY2023Q1 sgry Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders
RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
11700000 usd
CY2024Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
323700000 usd
CY2023Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
345800000 usd
CY2024Q1 sgry Variable Interest Entity Number Of Facilities
VariableInterestEntityNumberOfFacilities
7 facility
CY2024Q1 sgry Variable Interest Entity Number Of Facilities
VariableInterestEntityNumberOfFacilities
14 physician_practice
CY2024Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
704600000 usd
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
693600000 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
26200000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
27100000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
2871000000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
2775100000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
77200000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
73300000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
2793800000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
2701800000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
257700000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
255300000 usd
CY2024Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
591400000 usd
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
587000000.0 usd
CY2024Q1 sgry Lease Right Of Use Asset
LeaseRightOfUseAsset
849100000 usd
CY2023Q4 sgry Lease Right Of Use Asset
LeaseRightOfUseAsset
842300000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
37800000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
37600000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
250500000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
248900000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
288300000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
286500000 usd
CY2024Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
26300000 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
25400000 usd
CY2024Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
678300000 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
668200000 usd
CY2024Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
704600000 usd
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
693600000 usd
CY2024Q1 sgry Lease Liability
LeaseLiability
992900000 usd
CY2023Q4 sgry Lease Liability
LeaseLiability
980100000 usd
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
15900000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
16400000 usd
CY2024Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
11800000 usd
CY2023Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
9400000 usd
CY2024Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
13000000.0 usd
CY2023Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
12300000 usd
CY2024Q1 sgry Finance Lease Cost
FinanceLeaseCost
24800000 usd
CY2023Q1 sgry Finance Lease Cost
FinanceLeaseCost
21700000 usd
CY2024Q1 sgry Variable And Short Term Lease Cost
VariableAndShortTermLeaseCost
5800000 usd
CY2023Q1 sgry Variable And Short Term Lease Cost
VariableAndShortTermLeaseCost
5200000 usd
CY2024Q1 us-gaap Lease Cost
LeaseCost
46500000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
43300000 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
15600000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
16100000 usd
CY2024Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
12400000 usd
CY2023Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
11700000 usd
CY2024Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
7500000 usd
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
6400000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
19200000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8900000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
12100000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
15400000 usd
CY2024Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
1357900000 usd
CY2023Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
1360100000 usd
CY2024Q1 us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
52200000 usd
CY2024Q1 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
51800000 usd
CY2024Q1 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
14300000 usd
CY2023Q4 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
57400000 usd
CY2023Q4 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
17800000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
5400000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-12400000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-24900000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
125972000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
125206000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
125972000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
125206000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
37800000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
37600000 usd
CY2024Q1 sgry Cost Report Liabilities Current
CostReportLiabilitiesCurrent
24000000.0 usd
CY2023Q4 sgry Cost Report Liabilities Current
CostReportLiabilitiesCurrent
23900000 usd
CY2024Q1 srt Payables To Customers
PayablesToCustomers
25800000 usd
CY2023Q4 srt Payables To Customers
PayablesToCustomers
23900000 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
22300000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
17800000 usd
CY2024Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
93600000 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
100900000 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
203500000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
204100000 usd
CY2024Q1 us-gaap Self Insurance Reserve
SelfInsuranceReserve
19100000 usd
CY2023Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
18200000 usd
CY2023Q4 us-gaap Estimated Insurance Recoveries
EstimatedInsuranceRecoveries
10200000 usd
CY2024Q1 us-gaap Estimated Insurance Recoveries
EstimatedInsuranceRecoveries
10200000 usd
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
717400000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
666200000 usd
CY2024Q1 sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
97500000 usd
CY2023Q1 sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
90100000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
28700000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-400000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
36700000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
26100000 usd
CY2024Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-47300000 usd
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-46800000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33700000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33700000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4900000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4200000 usd
CY2024Q1 sgry Business Combination Integration Related Costs And Merger Costs
BusinessCombinationIntegrationRelatedCostsAndMergerCosts
18900000 usd
CY2023Q1 sgry Business Combination Integration Related Costs And Merger Costs
BusinessCombinationIntegrationRelatedCostsAndMergerCosts
12800000 usd
CY2024Q1 sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-1500000 usd
CY2023Q1 sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-10500000 usd
CY2024Q1 sgry Gain Loss Related To Litigation Settlement And Regulatory Change Impact
GainLossRelatedToLitigationSettlementAndRegulatoryChangeImpact
1200000 usd
CY2023Q1 sgry Gain Loss Related To Litigation Settlement And Regulatory Change Impact
GainLossRelatedToLitigationSettlementAndRegulatoryChangeImpact
-8000000.0 usd
CY2024Q1 sgry Undesignated Derivative Activity
UndesignatedDerivativeActivity
0 usd
CY2023Q1 sgry Undesignated Derivative Activity
UndesignatedDerivativeActivity
-600000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
400000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2024Q1 sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
97500000 usd
CY2023Q1 sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
90100000 usd
CY2024Q1 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
17400000 usd
CY2023Q1 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
12500000 usd
CY2024Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1500000 usd
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
300000 usd
CY2024Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
1800000 usd
CY2023Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-3000000 usd
CY2024Q1 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
600000 usd
CY2023Q1 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
600000 usd
CY2023Q1 sgry Interest Expense Impact Of Change In Letter Of Protection Regulation
InterestExpenseImpactOfChangeInLetterOfProtectionRegulation
4400000 usd
CY2024Q1 us-gaap Assets
Assets
6975600000 usd
CY2023Q4 us-gaap Assets
Assets
6876700000 usd
CY2024Q1 us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
21000000.0 usd
CY2023Q1 us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
24300000 usd
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0001638833-24-000113-index-headers.html Edgar Link pending
0001638833-24-000113-index.html Edgar Link pending
0001638833-24-000113.txt Edgar Link pending
0001638833-24-000113-xbrl.zip Edgar Link pending
a2024q1exhibit311.htm Edgar Link pending
a2024q1exhibit312.htm Edgar Link pending
a2024q1exhibit321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sgry-20240331.htm Edgar Link pending
sgry-20240331.xsd Edgar Link pending
sgry-20240331_g1.jpg Edgar Link pending
sgry-20240331_def.xml Edgar Link unprocessable
sgry-20240331_lab.xml Edgar Link unprocessable
sgry-20240331_htm.xml Edgar Link completed
Show.js Edgar Link pending
sgry-20240331_cal.xml Edgar Link unprocessable
sgry-20240331_pre.xml Edgar Link unprocessable